Microsatellite Stable Metastatic Colorectal Cancer (DBCOND0144860)
Identifiers
- Synonyms
- Metastatic Microsatellite Stable Colorectal Cancer / Metastatic Microsatellite-stable Colorectal Cancer
Associated Data
- Indicated Drugs and Targets
- Not Available
- Clinical Trials
Identifier Title Drug(s) Purpose Phase Status NCT06603818 Immunotherapies in Combination With Stereotactic Body Radiation Radiotherapy in Microsatellite Stable (MSS) Metastatic Colorectal Cancer (mCRC) treatment 2 not_yet_recruiting NCT05167409 A Study of Evorpacept (ALX148) With Cetuximab and Pembrolizumab for Refractory Microsatellite Stable Metastatic Colorectal Cancer treatment 2 active_not_recruiting NCT05963490 Regorafenib Alone or in Combination With Hypofractionated/Low-dose Radiotherapy Plus Toripalimab for Metastatic Colorectal Cancer treatment 2 recruiting NCT06525428 Standard Systemic Therapy Combined With High/Low-dose Radiotherapy Plus Toripalimab for Metastatic Colorectal Cancer treatment 2 recruiting NCT04575922 Nivolumab+Ipilimumab+RT in MSS mCRC treatment 2 unknown_status NCT05768503 Comparing Chidamide+Sintilimab+Bev With Standard Second-line FOLFIRI+Bev in Advanced MSS/pMMR mCRC treatment 3 recruiting NCT06012734 LB-100 (PP2A Inhibitor) and Atezolizumab (PD-L1 Inhibitor) in Metastatic Colorectal Cancer Patients treatment 1 recruiting NCT04724239 Sintilimab and Chidamide in Combination With or Without IBI305 in Advanced or Metastatic pMMR/MSS Colorectal Carcinoma treatment 2 active_not_recruiting NCT04068610 COLUMBIA-1: Novel Oncology Therapies in Combination With Chemotherapy and Bevacizumab as First- Line Therapy in MSS-CRC treatment 1 / 2 terminated NCT05205330 CR6086/AGEN2034 Combination in Stage IV pMMR - MSS CRC, and Other Metastatic GI Cancers treatment 1 / 2 recruiting